EVMN
Evommune, Inc.
NYSE · Healthcare · Biotechnology · US
$12.27
+2.25%Institutional positioning
13F filings over the trailing two quarters
New 38Increased 26Reduced 12Sold out 81
| Filer | Action | Shares | Filed |
|---|---|---|---|
| EQT FUND MANAGEMENT S.A R.L. | Unchanged | 4,929,633 | May 14, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Increased | 3,494,638 | May 15, 2026 |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | Unchanged | 1,926,943 | May 14, 2026 |
| ANDERA PARTNERS | Unchanged | 1,897,362 | May 11, 2026 |
| RTW INVESTMENTS, LP | Increased | 1,502,235 | May 15, 2026 |
| JPMORGAN CHASE & CO | Increased | 1,459,420 | May 13, 2026 |
| BIOIMPACT CAPITAL LLC | Increased | 1,455,863 | May 15, 2026 |
| NAN FUNG GROUP HOLDINGS LTD | Unchanged | 1,441,032 | May 14, 2026 |
| SymBiosis Capital Partners, LLC | Unchanged | 1,280,778 | May 12, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | Increased | 1,209,129 | May 15, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | Increased | 1,119,021 | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | New Position | 896,700 | May 18, 2026 |
| MARSHALL WACE, LLP | Reduced | 879,728 | May 15, 2026 |
| BAKER BROS. ADVISORS LP | New Position | 847,390 | May 15, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | New Position | 726,362 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings